Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital.

Neither phenobarbital nor everolimus administered at several time points after SE onset prevented the development of SRS. Nonetheless, we demonstrate a practical and moderate-throughput screen for potential antiepileptogenic agents in a rat model of TLE.